|
|
Volumn 111, Issue 9, 2001, Pages 729-730
|
|
Chelation therapy for coronary artery disease: Panacea or quackery?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ASCORBIC ACID;
CHOLESTEROL;
CHOLESTEROL ESTER;
COLLAGEN;
COPPER;
EDETIC ACID;
FATTY ACID;
FIBRINOGEN RECEPTOR;
FREE RADICAL;
HEPARIN;
IRON;
LIPOPROTEIN;
LOW DENSITY LIPOPROTEIN;
MAGNESIUM SULFATE;
PARATHYROID HORMONE;
PROTEOGLYCAN;
PYRIDOXINE;
VITAMIN B COMPLEX;
ANGINA PECTORIS;
ARTERY CALCIFICATION;
ATHEROSCLEROTIC PLAQUE;
CALCIUM TRANSPORT;
CHELATION THERAPY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY BLOOD FLOW;
CORONARY ARTERY DISEASE;
CORONARY VASCULAR RESISTANCE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG MECHANISM;
DRUG SAFETY;
EDITORIAL;
HEMOCHROMATOSIS;
HUMAN;
LIPID PEROXIDATION;
META ANALYSIS;
OXIDATIVE STRESS;
PARATHYROID HORMONE RELEASE;
PRIORITY JOURNAL;
QUACKERY;
SIDE EFFECT;
THROMBOCYTE AGGREGATION INHIBITION;
TREATMENT OUTCOME;
VITAMIN SUPPLEMENTATION;
CHELATION THERAPY;
CORONARY DISEASE;
EVIDENCE-BASED MEDICINE;
HUMANS;
|
|
EID: 0035893898
PISSN: 00029343
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9343(01)01056-7 Document Type: Editorial |
|
Times cited : (9)
|
|
References (13)
|
